Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;43(6):2621-2626.
doi: 10.1007/s10571-023-01342-8. Epub 2023 Mar 28.

Potential Prion Involvement in Long COVID-19 Neuropathology, Including Behavior

Affiliations
Review

Potential Prion Involvement in Long COVID-19 Neuropathology, Including Behavior

George B Stefano et al. Cell Mol Neurobiol. 2023 Aug.

Abstract

Prion' is a term used to describe a protein infectious particle responsible for several neurodegenerative diseases in mammals, e.g., Creutzfeldt-Jakob disease. The novelty is that it is protein based infectious agent not involving a nucleic acid genome as found in viruses and bacteria. Prion disorders exhibit, in part, incubation periods, neuronal loss, and induce abnormal folding of specific normal cellular proteins due to enhancing reactive oxygen species associated with mitochondria energy metabolism. These agents may also induce memory, personality and movement abnormalities as well as depression, confusion and disorientation. Interestingly, some of these behavioral changes also occur in COVID-19 and mechanistically include mitochondrial damage caused by SARS-CoV-2 and subsequenct production of reactive oxygen species. Taken together, we surmise, in part, long COVID may involve the induction of spontaneous prion emergence, especially in individuals susceptible to its origin may thus explain some of its manesfestions post-acute viral infection.

Keywords: COVID-19; Confusion; Depression; Long COVID; Mitochondria; Prion; Prion disorders; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Fig. 1
Fig. 1
Hypothetical mechanistic illustration of prion and SARS-CoV-2 mitochondrial targeting. Prions are infectious proteinaceous particles that have been functionally associated with the progression of major human neurodegenerative disorders such as Creutzfeldt-Jakob disease. Empirically elucidated modes of actions of infectious prions include multiple inhibitory patterns adversely affecting normative neural communication as well as initiation of apoptotic or necrotic neural damage. Furthermore, a likely mechanism of prion-related neural dysfunction may also involve aberrant restitution of native conformation of abnormally folded cellular proteins. These pathophysiological effects may be potentially due to loss of normative proteasome functioning due to enhanced reactive oxygen species associated with compromised mitochondria energy metabolism. Infectious prion diseases may also induce memory, personality and movement abnormalities as well as depression, confusion and disorientation. Interestingly, some of these same behavioral sequelae have also been observed to occur subsequent to COVID-19 and may also share pathogenic mitochondrial damage caused by SARS-CoV-2 infection with subsequent production of ROS or RNS. Taken together, we speculate that pathophysiological effects of long COVID may involve the induction of spontaneous production of infectious prion species. Interestingly, mitochondria may represent the central focus of both induced disorders

References

    1. Benz D, Cadet P, Mantione K, Zhu W, Stefano GB (2002) Tonal nitric oxide and health: a free radical and a scavenger of free radicals. Med Sci Monit 8(1):1–4 - PubMed
    1. Choi SI, Ju WK, Choi EK, Kim J, Lea HZ, Carp RI, Wisniewski HM, Kim YS (1998) Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol 96(3):279–286. 10.1007/s004010050895 - PubMed
    1. Colini Baldeschi A, Zattoni M, Vanni S, Nikolic L, Ferracin C, La Sala G, Summa M, Bertorelli R, Bertozzi SM, Giachin G, Carloni P, Bolognesi ML, De Vivo M, Legname G (2022) Innovative non-PrP-targeted drug strategy designed to enhance prion clearance. J Med Chem 65(13):8998–9010. 10.1021/acs.jmedchem.2c00205 - PMC - PubMed
    1. De Armond SJ, Bouzamondo E (2002) Fundamentals of prion biology and diseases. Toxicology 181–182:9–16. 10.1016/s0300-483x(02)00249-4 - PubMed
    1. de la Torre JC, Stefano GB (2000) Evidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide. Brain ResRev 34:119–136 - PubMed